We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The use of amorphous solid dispersions (ASDs), in which the active(s) is dispersed in a hydrophilic, water soluble excipient or matrix, is a widely recognised strategy for enhancing the bioavailability of poorly soluble drugs.